Abstract: Poster Presentations |


Alain Tremblay, MD*; David R. Stather, MD; Charity Greene, FCSMLS; Lori Maxwell, RVT; Margaret M. Kelly, MBChB
Author and Funding Information

University of Calgary, Calgary, AB, Canada


Chest. 2008;134(4_MeetingAbstracts):p142002. doi:10.1378/chest.134.4_MeetingAbstracts.p142002
Text Size: A A A
Published online


PURPOSE: To evaluate the effectiveness of decreasing doses of two sclerosing agents, silver nitrate (SN) and Doxycycline (D), when administered daily over 1, 5 and 14 days.

METHODS: In-vivo experiment in rabbit pleurodesis model consisting of intrapleural administration of D, SN or placebo (normal saline - NS) daily for 1, 5 or 14 days. Pleurodesis was graded according to an 8 point scale, with a score of ≥5 considered significant for pleurodesis.

RESULTS: Table 1 describes the mean pleurodesis scores for each dose regimen tested. The lowest concentration of SN (2ml/kg) leading to pleurodesis scores ≥ 5 were 0.425%, 0.085% and 0.050% for the single day, 5 day and 14 day administration protocols respectively. Pleurodesis score was significantly higher in the 14 day versus single day administration group for SN at the 0.05% dose. In the D groups, single day administration of a 10 mg/kg dose achieved a score of 4.5, and only 2.5 at the 5 mg/kg dose. Repeating the 5-mg/kg dose for 5 and 14 days lead to a score of 5 and 7.5 respectively, the latter being statistically significant as compared to the single day 5 mg/kg dose (p=0 .014) as well as 14 day placebo dose (p= 0.005). At the lowest dose tested of 1 mg/kg, neither the 5 day nor 14 day regimen resulted in significant pleurodesis.

CONCLUSION: Repeated administration of low doses of sclerosing agents can lead to effective pleurodesis in this animal model. The dose reduction achieved is especially significant for silver nitrate where a near ten-fold reduction in dose could lead to effective pleurodesis when administered over 14 days.

CLINICAL IMPLICATIONS: Given that toxicity of sclerosing agents used for pleurodesis are dose dependent, administration of lower doses in a repeated fashion may result in effective pleurodesis while minimizing side effects.

DISCLOSURE: Alain Tremblay, None.

Wednesday, October 29, 2008

1:00 PM - 2:15 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543